Introduction: A New Era in Breast Cancer Treatment The oncology landscape has undergone significant transformation, with targeted therapies reshaping treatment approaches. Among the most promising innovations, Elacestrant, an oral selective estrogen receptor degrader (SERD), is gaining strong traction in the breast cancer field. DelveInsight’s detailed analysis of the Elacestrant Market...